Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
Huelves
Lorena
L
Gracia
Matilde
M
Del Prado
Gema
G
Rodríguez-Cerrato
Violeta
V
Martínez-Marín
Carmina
C
Ponte
Carmen
C
Soriano
Francisco
F
Coronel
Pilar
P
Gimeno
Mercedes
M
Blanco
Jorge
J
D018784:Abdominal Abscess / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001442:Bacteroides Infections / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D001441:Bacteroides fragilis / Q000187:drug effects*; D002513:Cephamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D006801:Humans; D051379:Mice; D018805:Sepsis / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D019980:Amoxicillin-Potassium Clavulanate Combination; C046079:cefminox